Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company.

Wednesday closed up by +0.71%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up by +1.03%, and the Nasdaq 100 Index ...

Pfizer Inc. (NYSE:PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is scheduled to meet ...

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

The Justice Department could push for the tech giant to sell off a business to end its lock on online search. But a move ...

Here's what investors need to know today. The Department of Justice (DOJ) has submitted a filing giving a federal court a ...

While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030.

CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

Albert Bourla, the CEO of pharmaceutical company Pfizer ($PFE), plans to meet with activist investor Starboard Value in ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...